NCT06043739View on ClinicalTrials.gov

Relative Bioavailability and Effect of Food Study With an Oral Mini-tablet Formulation of Filgotinib in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 22, 2023

Primary Completion Date

October 27, 2023

Study Completion Date

November 12, 2023

Conditions
Bioavailability
Interventions
DRUG

Filgotinib

Commercially developed film-coated tablet administered orally

DRUG

Filgotinib

Film-coated mini-tablets administered orally

Trial Locations (1)

H3P 3P1

Altasciences, Montreal

Sponsors

Lead Sponsor

Galapagos NV
All Listed Sponsors
lead

Galapagos NV

INDUSTRY